Benjamin Hickey is CCO & VP at Mirati Therapeutics, Inc. (MRTX). They have made 11 open-market trades across 2 companies since 2021, most recently 2026-02-27.
CIK 0001753055
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 11 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BMY | SELL | 2025-05-09 | 2025-05-13 | $38.16 | $4K | +0.3% | +8.5% | -1.7% |
| MRTX | SELL | 2024-01-16 | 2024-01-18 | $59.02 | $151K | N/A | N/A | N/A |
| MRTX | SELL | 2024-01-08 | 2024-01-09 | $58.92 | $246K | -0.5% | N/A | N/A |
| MRTX | SELL | 2023-12-13 | 2023-12-14 | $56.67 | $252K | +2.9% | +3.1% | N/A |
| MRTX | SELL | 2023-01-17 | 2023-01-19 | $42.38 | $66K | +23.1% | +4.5% | -2.1% |
| MRTX | SELL | 2023-01-09 | 2023-01-10 | $45.37 | $189K | +19.4% | +22.3% | -6.7% |
| MRTX | SELL | 2022-12-21 | 2022-12-21 | $40.41 | $263K | +12.4% | +7.3% | -4.3% |
| MRTX | SELL | 2022-01-18 | 2022-01-18 | $120.48 | $151K | -2.7% | -21.6% | -33.7% |
| MRTX | SELL | 2022-01-07 | 2022-01-07 | $135.94 | $534K | -10.1% | -8.3% | -34.8% |
| MRTX | SELL | 2021-03-19 | 2021-03-22 | $176.44 | $836K | -1.6% | -11.7% | -10.0% |
| MRTX | SELL | 2021-01-07 | 2021-01-08 | $216.33 | $897K | -0.7% | -2.0% | -22.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.